Source:http://linkedlifedata.com/resource/pubmed/id/19740324
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Suppl
|
pubmed:dateCreated |
2009-9-10
|
pubmed:abstractText |
Granulocyte colony-stimulating factor (G-CSF)-mobilized donor graft tissue used for peripheral blood stem cell transplantation contains a large number of immature myeloid cells that suppress alloreactive donor T cells, resulting in an inhibition of acute graft-versus-host disease (GVHD). However, the molecular mechanism underlying the suppressive function of immature myeloid cells is not fully understood. Here, we investigated whether indoleamine 2,3-dioxygenase (IDO) is related to the suppressive mechanism of G-CSF-induced immature myeloid cells (gMCs). We found that Gr-1(+) CD11b(+) cells were highly induced in G-CSF-injected donor graft tissue, which is a phenotype of immature myeloid cells, resulting in an inhibition of acute GVHD lethality by suppressing alloreactive donor T-cell expansion. IDO was not detected in primary isolated gMCs; however, this enzyme was markedly induced after treatment with interferon-gamma (IFN-gamma). This level was significantly higher in IFN-gamma-treated gMCs than in bone marrow myeloid cells, which promote alloreactive T-cell responses. We next investigated the functional role of IDO in gMC-mediated inhibition of acute GVHD lethality. We found no changes in gMC-mediated survival or alloreactive donor T-cell suppression when IDO activity was blocked using 1-methyl tryptophan. In addition, there was no difference in gMC-mediated survival rates between recipients transferred with either wild-type gMCs or IDO(-/-) gMCs. Taken together, our data suggest that gMC-mediated inhibition of lethal acute GVHD is through an IDO-independent mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1365-2567
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e632-40
|
pubmed:dateRevised |
2010-9-2
|
pubmed:meshHeading |
pubmed-meshheading:19740324-Acute Disease,
pubmed-meshheading:19740324-Animals,
pubmed-meshheading:19740324-Cell Transplantation,
pubmed-meshheading:19740324-Female,
pubmed-meshheading:19740324-Graft Rejection,
pubmed-meshheading:19740324-Graft vs Host Disease,
pubmed-meshheading:19740324-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:19740324-Immunosuppression,
pubmed-meshheading:19740324-Indoleamine-Pyrrole 2,3,-Dioxygenase,
pubmed-meshheading:19740324-Interferon-gamma,
pubmed-meshheading:19740324-Mice,
pubmed-meshheading:19740324-Mice, Inbred BALB C,
pubmed-meshheading:19740324-Mice, Inbred C57BL,
pubmed-meshheading:19740324-Mice, Knockout,
pubmed-meshheading:19740324-Myeloid Cells,
pubmed-meshheading:19740324-T-Lymphocytes
|
pubmed:year |
2009
|
pubmed:articleTitle |
Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
|
pubmed:affiliation |
Department of Hemato/Oncology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|